PREVALENCE, PATIENT CHARACTERISTICS, AND TREATMENT OF GOUT AND ASYMPTOMATIC HYPERURICEMIA IN JAPAN: CROSS-SECTIONAL STUDY OF A HEALTH INSURANCE CLAIMS DATABASE

被引:0
|
作者
Koto, Ruriko [1 ]
Nakajima, Akihiro [2 ]
Horiuchi, Hideki [1 ]
Yamanaka, Hisashi [3 ]
机构
[1] Teijin Pharma Ltd, Dept Med Sci, Tokyo, Japan
[2] Teijin Pharma Ltd, Pharmaceut Dev Adm Dept, Tokyo, Japan
[3] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo, Japan
关键词
POPULATION;
D O I
10.1136/annrheumdis-2019-eular.4466
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FRI0678
引用
收藏
页码:1037 / 1037
页数:1
相关论文
共 50 条
  • [1] Prevalence of gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database
    Ito, Shuichi
    Torii, Tomoko
    Nakajima, Akihiro
    Iijima, Takeshi
    Murano, Hiroshi
    Horiuchi, Hideki
    Yamanaka, Hisashi
    Honda, Masataka
    [J]. BMC PEDIATRICS, 2020, 20 (01)
  • [2] Prevalence of gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database
    Shuichi Ito
    Tomoko Torii
    Akihiro Nakajima
    Takeshi Iijima
    Hiroshi Murano
    Hideki Horiuchi
    Hisashi Yamanaka
    Masataka Honda
    [J]. BMC Pediatrics, 20
  • [3] Real-world treatment of gout and asymptomatic hyperuricemia: A cross-sectional study of Japanese health insurance claims data
    Koto, Ruriko
    Nakajima, Akihiro
    Horiuchi, Hideki
    Yamanaka, Hisashi
    [J]. MODERN RHEUMATOLOGY, 2021, 31 (01) : 261 - 269
  • [4] Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database
    Honda, Masataka
    Horiuchi, Hideki
    Torii, Tomoko
    Nakajima, Akihiro
    Iijima, Takeshi
    Murano, Hiroshi
    Yamanaka, Hisashi
    Ito, Shuichi
    [J]. BMC PEDIATRICS, 2021, 21 (01)
  • [5] Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database
    Masataka Honda
    Hideki Horiuchi
    Tomoko Torii
    Akihiro Nakajima
    Takeshi Iijima
    Hiroshi Murano
    Hisashi Yamanaka
    Shuichi Ito
    [J]. BMC Pediatrics, 21
  • [6] The reality of treatment for hyperuricemia and gout in Japan: A historical cohort study using health insurance claims data
    Akari, Seigo
    Nakamura, Takashi
    Furusawa, Kenichi
    Miyazaki, Yuichi
    Kario, Kazuomi
    [J]. JOURNAL OF CLINICAL HYPERTENSION, 2022, 24 (08): : 1068 - 1075
  • [7] Current treatment patterns and medical costs for multiple myeloma in Japan: a cross-sectional analysis of a health insurance claims database
    Uno, Shuji
    Goto, Rei
    Suzuki, Kenshi
    Iwasaki, Kosuke
    Takeshima, Tomomi
    Ohtsu, Tomoko
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (02) : 166 - 173
  • [8] Prevalence of Gout and Hyperuricemia in Taiwan: A Hospital-Based, Cross-Sectional Study
    Lai, Shih-Wei
    Liu, Chiu-Shong
    Lin, Tsann
    Lin, Cheng-Chieh
    Lai, Hsueh-Chou
    Liao, Kuan-Fu
    [J]. SOUTHERN MEDICAL JOURNAL, 2009, 102 (07) : 772 - 773
  • [9] Medical Students' Perspective and Knowledge of Asymptomatic Hyperuricemia and Gout Management: A Cross-Sectional Study
    Furlan, Sanja
    Rusic, Doris
    Kumric, Marko
    Bozic, Josko
    Vilovic, Marino
    Vilovic, Tina
    Rada, Marko
    Cerovecki, Venija
    Tomicic, Marion
    [J]. HEALTHCARE, 2021, 9 (12)
  • [10] A RETROSPECTIVE, CROSS SECTIONAL STUDY ON THE PREVALENCE OF HYPERURICEMIA USING A HEALTHCARE DATABASE IN JAPAN
    Higa, S.
    Yoshida, M.
    Shima, D.
    Ii, Y.
    Kitazaki, S.
    Yamamoto, Y.
    Fujimoto, Y.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A578 - A578